Francisco Rodríguez-Esparragón is a researcher at the Research Unit of the Hospital Universitario de Gran Canaria Dr. Negrín. He is affiliated with the Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FCIISC) and the Spanish Biomedical Research Network Centre for Infectious Diseases (CIBERINFEC) under the Instituto de Salud Carlos III. He holds a PhD in Medicine and has a strong background in molecular biology, bioinformatics, and translational research. His work focuses on the molecular mechanisms underlying complex diseases, including cardiovascular, renal, cancer, and neurodegenerative disorders. His research integrates experimental and computational approaches, with particular emphasis on genomic and epigenomic analyses, biomarker discovery, and the application of bioinformatics tools to understand disease pathways and therapeutic targets. He has participated in multiple competitive research projects and has authored publications in international peer-reviewed journals. His research interests include oxidative stress, cell signalling, neurodegeneration, disease genetics, molecular biomarkers, and targeted therapies, as well as the genetic and biochemical evaluation of adjunctive and neuroprotective strategies.